Osteoarthritis News and Research

Latest Osteoarthritis News and Research

Chronic users NSAIDs have greater risk of bleeding and visible damage to their small intestine

According to a study published today in the American Gastroenterological Association (AGA) journal Clinical Gastroenterology and Hepatology, chronic users of non-steroidal anti-inflammatory drugs (NSAIDs) have an increased risk of bleeding and visible damage to their small intestine.

4 Jan 2005

Signaling molecule involved in osteoarthritis identified

Using naturally-occurring mutant mice with a defective collagen gene, scientists at Harvard have identified a signaling molecule involved in one of the most common causes of disability among the elderly in the United States, osteoarthritis.

4 Jan 2005

Laser therapy may be considered by arthritis patients as a safe Vioxx alternative

Adverse events of long term medication with NSAIDs and particularly coxibs, has recently received much attention in the Vioxx matter. Consequently, Vioxx has been withdrawn and Prexige has been withheld from the market. The whole group of coxibs, are now under special observation by drug agencies in both Europe and the United States.

27 Dec 2004

Public health advisory for the use of non-steroidal anti-inflammatory drug products

The Food and Drug Administration (FDA) has issued a Public Health Advisory summarizing the agency's recent recommendations concerning the use of non-steroidal anti-inflammatory drug products (NSAIDs), including those known as COX-2 selective agents.

23 Dec 2004

Arthritis drug caution advised by New Zealand experts

An expert New Zealand committee reviewing the safety of a group of arthritis drugs called COX-2 inhibitors has reinforced UK advice cautioning against their routine use where safe and effective alternatives are available.

21 Dec 2004

No increased cardiovascular risk seen in elderly patients taking Celebrex

The National Institutes of Health has reported in an Alzheimer's Disease prevention study that there was no increased cardiovascular risk seen in elderly patients taking Celebrex (400 mg daily) for up to three years.

21 Dec 2004

ChondroGene and Pfizer osteoarthritis collaboration

ChondroGene reported today that it has entered into a new two-year research collaboration with Pfizer for the identification of novel therapeutic targets and biomarkers for the treatment and diagnosis of osteoarthritis (OA).

21 Dec 2004

New advice on anti-inflammatory drugs called Cox-2 Inhibitors, including Celebrex

Patients who are taking Celebrex, Bextra and Arcoxia should make a non-urgent appointment with their GP to review their treatment. Patients who have established heart disease or who are at high risk of stroke will have their treatment changed.

21 Dec 2004

5000 year old system of medicine provides pain relief for people with osteoarthritis of the knee

A 5000 year old system of medicine, acupuncture provides pain relief and improves function for people with osteoarthritis of the knee and serves as an effective complement to standard care.

20 Dec 2004

Magnetic bracelets reduce pain in osteoarthritis of the hip and knee

Osteoarthritis affects around 760,000 people in the United Kingdom, producing over 3 million general practice consultations in 2000. Manufacturers of magnetic bracelets claim that they can reduce pain and worldwide sales were estimated at £2.6bn ($5bn) in 1999. But evidence about their effectiveness is contradictory.

20 Dec 2004

Celebrex suspension

The National Institutes of Health (NIH) announced that it has suspended the use of COX-2 inhibitor celecoxib (Celebrex™ Pfizer, Inc.) for all participants in a large colorectal cancer prevention clinical trial conducted by the National Cancer Institute (NCI).

19 Dec 2004

Benefits of weight loss may depend on alignment of affected leg, study suggests

A painful and sometimes crippling disease characterized by progressive cartilage loss, osteoarthritis (OA) of the knee affects an estimated 6 percent of adults over age 30.

2 Dec 2004

Topical cream alternative to Vioxx

A clinical study recently published in The Journal of Rheumatology concludes that a topical cream consisting of a blend of natural oils called cetylated fatty acids significantly increased range of motion and physical performance in patients with osteoarthritis of the knee with no reported side effects.

24 Nov 2004

Patients with knee osteoarthritis should avoid long term use of non-steroidal anti-inflammatory drugs

Current guidelines recommend the use of oral NSAIDs in the treatment of knee osteoarthritis and they are used regularly by half of all patients with painful osteoarthritis.

23 Nov 2004

Acupuncture better than drugs alone for osteoarthritis of the knee

Acupuncture, as a complementary therapy to drug treatment for osteoarthritis of the knee, is more effective than drug treatment alone, find researchers from Spain in this week's BMJ.

18 Nov 2004

Cyclooxygenase (COX) inhibitors tested in both prevention and treatment clinical trials

Numerous compounds are examined by the National Cancer Institute (NCI) for their potential to prevent or treat cancer. One class of compounds, cyclooxygenase (COX) inhibitors, is currently being tested in both prevention and treatment clinical trials.

4 Nov 2004

Study indicates potential of alendronate and estrogen progression of osteoarthritis

Osteoarthritis (OA) of the knee, a chronic inflammatory disease marked by cartilage degradation and bone abnormalities, is a leading cause of disability among elderly people in the United States.

4 Nov 2004

Researcher finds no long-term benefit of using glucosamine for knee joint pain

A popular food supplement used to treat osteoarthritis pain in knee joints has been shown to have no long-term beneficial effect, according to a national study conducted by a University of British Columbia post-doctoral fellow working at the Arthritis Research Centre of Canada

1 Nov 2004

Study clearly showed the benefit of weight loss in terms of pain, function and quality of life

Over 18 months, researchers at University Hospitals of Cleveland and Case Western Reserve University studied the frequency and prevalence of musculoskeletal (MSK) complaints in obese patients before and after undergoing gastric bypass surgery.

21 Oct 2004

Weight loss surgery reduces components of metabolic syndrome in obese patients

Obese patients who underwent surgical treatment for weight loss had significant reductions in the components of the metabolic syndrome one year after surgery, according to an article in the October issue of The Archives of Surgery.

18 Oct 2004

Osteoarthritis News and Research

Latest Osteoarthritis News and Research

Chronic users NSAIDs have greater risk of bleeding and visible damage to their small intestine

Signaling molecule involved in osteoarthritis identified

Laser therapy may be considered by arthritis patients as a safe Vioxx alternative

Public health advisory for the use of non-steroidal anti-inflammatory drug products

Arthritis drug caution advised by New Zealand experts

No increased cardiovascular risk seen in elderly patients taking Celebrex

ChondroGene and Pfizer osteoarthritis collaboration

New advice on anti-inflammatory drugs called Cox-2 Inhibitors, including Celebrex

5000 year old system of medicine provides pain relief for people with osteoarthritis of the knee

Magnetic bracelets reduce pain in osteoarthritis of the hip and knee

Celebrex suspension

Benefits of weight loss may depend on alignment of affected leg, study suggests

Topical cream alternative to Vioxx

Patients with knee osteoarthritis should avoid long term use of non-steroidal anti-inflammatory drugs

Acupuncture better than drugs alone for osteoarthritis of the knee

Cyclooxygenase (COX) inhibitors tested in both prevention and treatment clinical trials

Study indicates potential of alendronate and estrogen progression of osteoarthritis

Researcher finds no long-term benefit of using glucosamine for knee joint pain

Study clearly showed the benefit of weight loss in terms of pain, function and quality of life

Weight loss surgery reduces components of metabolic syndrome in obese patients

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Osteoarthritis News and Research

Latest Osteoarthritis News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in